Background: Biliary atresia (BA) is an idiopathic progressive inflammation and fibrosclerosis
of the extra and intrahepatic bile ducts. Aim: To measure the serum levels of IL-6 and IL-8 in …

Biliary atresia (BA) is a neonatal obliterative cholangiopathy of unknown etiology. Despite
the Kasai procedure, hepatic fibrosis and portal hypertension (PH) still occur. Interleukin-8 …

Objective: Biliary atresia is a neonatal obstructive cholangiopathy characterized by a
destructive, obliterative process affecting both the intrahepatic and extrahepatic ducts of the …

Objectives Although the exact etiology of biliary atresia (BA) is still elusive, inflammation
plays a key role. Release of proinflammatory cytokines from activated immune cells …

Background T helper (Th) cell cytokines modulate inflammation and play a role in biliary
atresia (BA). The aim of the study is a cross-sectional assessment of the levels of Th …

Background/Purpose: Antiinflammatory cytokine (interleukin [IL]-1ra) and proinflammatory
cytokines (tumor necrosis factor [TNF]-[alpha] and IL-6) appear to play important roles in the …

Introduction Biliary atresia (BA) is a fatal disease in children. Its main pathological feature is
progressive immune-mediated cholangiopathy. Interleukin (IL)-12, IL-18, and interferon …

Objectives: Our previous work demonstrated altered messenger RNA expression of integrin
β-5 and-8, using an in silico analysis of publically available data from patients with biliary …

AIM OF STUDY: Lymphocyte-mediated inflammation within the liver and bile ducts has been
proposed as a potential mechanism in the pathogenesis of biliary atresia (BA). Recent …

Background/Purpose: Interleukin-18 (IL-18)/interferon-γ-inducing factor (TGIF) is a novel
proinflammatory cytokine that can induce interferon gamma (IFN-γ). In addition, IL-18 …